Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
771.12 | -48.81% | -27.8% | 694,320.6 | 0.66% | 2.63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
912.90 | -2.1% | 18.21% | 4,066,820.23 | 1.02% | 18.5% |
|
NYSE:MRK
Merck
|
130.88 | -9.8% | 3.42% | 331,493.69 | 2.34% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
121.66 | 18.34% | 40.96% | 188,601.59 | 2.01% | 15.98% |
|
SWX:NOVN
Novartis
|
92.62 | 9.02% | 22.51% | 188,982.44 | 3.54% | 4.67% |
|
NYSE:PFE
Pfizer
|
28.92 | 7.37% | 37.31% | 163,877.87 | 5.83% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
90.24 | 17.91% | 36.66% | 112,810.55 | 4.15% | 8.19% |
|
LSE:GSK
GSK
|
17.84 | 6.89% | 22.64% | 72,731.8 | 3.2% | 0.79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.11 | 61.44% | 71.76% | 89,415.39 | 5.39% | 13.54% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4138.00 | 0% | 0% | 6,492,248.28 | 4.74% | 0% |
|
XTRA:BAYN
Bayer
|
28.65 | 67.13% | 83.44% | 28,146.45 | 0.38% | 1.47% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.30 | -46.24% | -42.78% | 18,462.04 | 0% | -2.6% |
|
NSEI:CIPLA
Cipla
|
1421.10 | 11.52% | 24.38% | 1,081,545.93 | 0.92% | 22.76% |
|
TSE:4523
Eisai
|
6866.00 | 0% | 0% | 1,968,631.52 | 2.33% | 0% |
|
BIT:REC
Recordati Industria Chimica e Farmaceutica
S.p.A. |
50.80 | 18.28% | 30.99% | 10,363.08 | 2.32% | 10.99% |
|
BME:ALM
Almirall
|
9.51 | -45.22% | 27.15% | 1,944.22 | 2.03% | -30.96% |
|
SZSE:002390
Guizhou Xinbang Pharmaceutical
|
3.81 | -7.03% | 16.21% | 9,446.38 | 1.47% | -7.79% |
|
KOSE:A069620
Daewoong pharmaceutical Co.,Ltd
|
111400.00 | 239.98% | 300.18% | 1,282,949.11 | 0.54% | 132.39% |
|
NasdaqGM:RVNC
Revance Therapeutics
|
3.16 | 0% | 0% | 447.08 | 0% | 0% |
|
NasdaqGS:LXRX
Lexicon Pharmaceuticals
|
1.84 | 0% | 0% | 428.45 | 0% | 0% |
